1 Therapeutic Products Act. 15 December 2000 ( Status as of 1 January 2019), The Federal Assembly of the Swiss Confederation:
https://www.admin.ch/opc/en/classified-compilation/20002716/index.html.
2 Regulation (EC) No 1901/2006 on medicinal products for paediatric use. 2006, European Parliament and Council of the European Union:
https://eur-lex.europa.eu/legal-content/DE/TXT/PDF/uri=CELEX:32006R1901&from=EN.
3 Wimmer S, Rascher W, Neubert A. How often do SmPCs Contain Contraindications and Special Warnings that are Specific for the Paediatric Population. Klin Padiatr, 2019. 231(4): p. 191–8.
4 Haniman A et al. Situationsanalyse der Zulassungsmassnahmen «pädiatrisches Prüfkonzept» und «wichtige Arzneimittel für seltene Krankheiten» bei Kindern. 2022, Interface Politikstudien Forschung Bratung AG:
https://www.bag.admin.ch/bag/de/home/das-bag/publikationen/evaluationsberichte/evalber-biomedizin-forschung.html.
5 Tilen R et al. Information in Swiss drug labels about use in children is limited and need standardisation. 2022: GSASA Kongress Luzern.
6 SAMW, Abgrenzung von Standardtherapie und experimenteller Therapie im Einzelfall (2014, adaptiert 2015).
7 Tilen R, et al. Development of the Swiss Database for dosing medicinal products in pediatrics. Eur J Pediatr, 2022. 181(3): p. 1221–31.
8 Gotta V, et al. In silico studies to evaluate dosing intervals associated with low risk of amikacin accumulation in preterm neonates. 2022: GSASA Kongress Luzern.
9 Ravix A, et al. Dosing optimization of amoxicillin in children treated for Lyme disease. 2022: GSASA Kongress Luzern.
10 Paioni P, et al. Gentamicin Population Pharmacokinetics in Pediatric Patients-A Prospective Study with Data Analysis Using the saemix Package in R. Pharmaceutics, 2021. 13(10): p. 1596.
11 Tilen R, et al. Pharmacogenetic Analysis of Voriconazole Treatment in Children. Pharmaceutics, 2022. 14(6): p. 1289.
12 Kägi W, et al. Situationsanalyse des Einsatzes der nationalen Datenbank zur Dosierung von Arzneimitteln bei Kindern «SwissPedDose». 2022, BSS Volkswirtschaftliche Beratung:
https://www.bag.admin.ch/bag/de/home/das-bag/publikationen/evaluationsberichte/evalber-biomedizin-forschung.html.